Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 244Melanoma 141Squamous Cell Carcinoma of Head and Neck 139Parkinson Disease 4, Autosomal Dominant Lewy Body 119Neoplasm Metastasis 104Triple Negative Breast Neoplasms 96Neoplasms 91Lung Neoplasms 91Breast Neoplasms 81Colorectal Neoplasms 70Carcinoma, Renal Cell 69Head and Neck Neoplasms 59Urinary Bladder Neoplasms 50Stomach Neoplasms 47Ovarian Neoplasms 46Endometrial Neoplasms 46Carcinoma, Transitional Cell 44Carcinoma, Hepatocellular 35Uterine Cervical Neoplasms 34Pancreatic Neoplasms 34Esophageal Neoplasms 27Prostatic Neoplasms 26Recurrence 25Carcinoma, Squamous Cell 25Carcinoma 25Sarcoma 24Brain Neoplasms 24Glioblastoma 23Hodgkin Disease 19Cholangiocarcinoma 19

Interventions

tremelimumab 4Ipilimumab 4lenvatinib 3durvalumab 3Nivolumab 3pembrolizumab 2balstilimab 2Pemetrexed 2Carboplatin 2Bevacizumab 2spartalizumab 1relatlimab 1poly ICLC 1osimertinib 1cemiplimab 1Vemurafenib 1Vascular Endothelial Growth Factor A 1Standard of Care 1Platinum 1Peptides 1Paclitaxel 1Opdualag 1Docetaxel 1Capecitabine 1Blood Specimen Collection 1Axitinib 1Antibodies, Bispecific 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Diabetes Mellitus, Insulin-Dependent, 12 × pembrolizumab × 1 year × Clear all
NCT04305054 2026-05-28

KEYMAKER-U02

Merck Sharp & Dohme LLC

Phase 1/2 Completed
335 enrolled
Dermatologic

Diabetes Mellitus, Insulin-Dependent, 12, Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT03530397 2026-05-19

A Study to Evaluate MEDI5752 in Subjects With Advanced Solid Tumors

MedImmune LLC

Phase 1 Active not recruiting
400 enrolled

Diabetes Mellitus, Insulin-Dependent, 12, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡